Liver disease epidemiology and burden in patients with alterations in plasma protein metabolism: German retrospective insurance claims analysis

doi:10.4254/wjh.v15.i10.1127

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2966)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

107

WORD

HTML

1477

Figures (1-4)

378

Tables (1-3)

303

Sum=2293

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

169

Download

395

Sum=564

Oct 27, 2023 (publication date) through Feb 7, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Oct 27, 2023; 15(10): 1127-1139
Published online Oct 27, 2023. doi: 10.4254/wjh.v15.i10.1127

Table 2 Diagnostic procedures within 12 mo after the index date, n (%)

Diagnostic procedure	Patients with APPM and liver disease: APPM cohort, n = 2680
Imaging procedure¹	1778 (66.3)
Laboratory test²	1366 (51.0)
Liver biopsy	207 (7.7)
AAT phenotyping	55 (2.1)
Liver function test³	13 (0.5)

Data are n (%).

¹Included sonographies, computed tomography scans, magnetic resonance imaging procedures, angiographies of the abdomen and magnetic resonance elastographies.

²Included albumin and bilirubin measurements.

³Liver function test with intravenous application of a ¹³C-labeled substrate.

AAT: Alpha-1 antitrypsin; APPM: Alterations in plasma protein metabolism.

Citation: Picker N, Hagiwara M, Baumann S, Marins EG, Wilke T, Ren K, Maywald U, Karki C, Strnad P. Liver disease epidemiology and burden in patients with alterations in plasma protein metabolism: German retrospective insurance claims analysis. World J Hepatol 2023; 15(10): 1127-1139
URL: https://www.wjgnet.com/1948-5182/full/v15/i10/1127.htm
DOI: https://dx.doi.org/10.4254/wjh.v15.i10.1127